In contrast, we found that RTK-SOS2-WT RAS signaling, but not allosteric SOS2 activation, is a critical mediator of mutant KRAS-driven transformation [81] by protecting KRAS-mutated cancer cells from anoikis [82]. This evidence concerns the gene KRAS and cancer.